Original Investigation

Bilateral Conversion Risk in Unilateral Retinoblastoma Using Age and Genetic Testing

JAMA Ophthalmology 10.1001/jamaophthalmol.2026.0143

March 12, 2026 at 11:00 AM EDT

Read the full article

Can age at diagnosis and genetic subtype predict metachronous bilateral conversion in initially unilateral retinoblastoma?In this cohort study including 1108 patients, 24 developed metachronous bilateral disease, and genetic testing in 316 patients identified 62 variant–positive and 254 variant–negative cases. All 15 -positive converters were diagnosed at the index presentation before age 9 months, whereas all 4 variant-negative converters were initially diagnosed after age 20 months.The findings suggest that age at diagnosis may stratify bilateral conversion risk: variant–positive patients diagnosed at 9 months or older represented a very low-risk subgroup warranting deescalated surveillance.

Corresponding Authors: Peiquan Zhao, MD, PhD (zhaopeiquan@xinhuamed.com.cn), and Tingyi Liang, MD (liangtingyi@xinhuamed.com.cn), Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No. 1665, Kongjiang Road, Shanghai 200092, China.

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks